At a glance

ClinicalIndex Comparison Record

N/ACompleted· 228 enrolled

Drug / intervention

Stress and Symptom Management Program 1 +1 morebehavioral

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03406208

NCT03406208N/ACompleted

Compare CT.gov

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Massachusetts General Hospital·interventional·Posted Jan 23, 2018·Updated Dec 24, 2025

In Brief

A clinical study evaluating Stress and Symptom Management Program 1 and Stress and Symptom Management Program 2 for Neurofibromatoses and 3 related conditions. Completed, enrolled 228 participants across 1 site.

Detailed Summary

The aims of this study are to compare the effect and durability of two stress and symptom management programs tailored for patients with neurofibromatosis on quality of life and psychosocial functioning.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsNeurofibromatoses, Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis

CountriesUnited States

CollaboratorsUnited States Department of Defense

Timeline

N/ACompletedFinished

201820192020202120222023202420252026

Enrollment StartOct 2017

First PostedJan 2018

Primary CompletionFeb 2022

TodayJul 2026

First PostedJan 23, 2018

Enrollment StartOct 1, 2017

Primary CompletionFeb 28, 2022

TodayJul 2, 2026

Enrollment to primary: 4.4 yearsPosted 8.4 years ago

Interventions

Stress and Symptom Management Program 1behavioral

The Stress and Symptom Management Program 1 (SMP1) introduces and reinforces stress and symptom management skills. The program consists of 8 weekly sessions (90 minutes each), delivered through live videoconferencing.

Stress and Symptom Management Program 2behavioral

The Stress and Symptom Management Program 2 (SMP2) introduces and reinforces stress and symptom management skills. The program consists of 8 weekly sessions (90 minutes each), delivered through live videoconferencing.